GLOBAL ANTIFUNGAL AGENTS(DRUGS, THERAPIES AND APPLICATIONS) MARKET FORECAST 2017-2025

  • You are here:
  • Home
  • Reports
  • GLOBAL ANTIFUNGAL AGENTS(DRUGS, THERAPIES AND APPLICATIONS) MARKET FORECAST 2017-2025

GLOBAL ANTIFUNGAL AGENTS(DRUGS, THERAPIES AND APPLICATIONS) MARKET FORECAST 2017-2025

The global antifungal agents market is expected to grow from $ 6400 million in 2016 to $12924 million by 2025, at a CAGR of 8.11 % between 2017 and 2025. The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The anti-fungal agent market is witnessing high growth in near future due to increasing awareness among people about various fungal infections etc. which helps in boosting this market. The topical drugs application is expected to dominate the global antifungal agents market. Topical drugs are those medications which are directly applied to the skin or the affected portion of the body.

The global antifungal agents market is expected to grow from $ 6400 million in 2016 to $12924 million by 2025, at a CAGR of 8.11 % between 2017 and 2025. The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The anti-fungal agent market is witnessing high growth in near future due to increasing awareness among people about various fungal infections etc. which helps in boosting this market.

The topical drugs application is expected to dominate the global antifungal agents market. Topical drugs are those medications which are directly applied to the skin or the affected portion of the body. These come in wide forms like pastes, ointments, powder and others. Most of the topical drugs have systematic effects because they are first absorbed by the skin and are then circulated. Proper handling of the topical drug is a major concern, because, mishandling of the drug can lead to complications. The oral drugs are anticipated to grow at a faster rate during the forecast period. Oral antifungal drugs include fluconazole, terbinafine, itraconazole, and ketoconazole. These oral antifungal drugs are reserved for serious infection for which topical antifungal agents are ineffective or inappropriate. Most of the oral antifungal drugs are the medicines which are available only through prescription and are available in dosage forms such as capsules, suspensions, and tablets.

Antifungal Agents Market

On the basis of the drug types, azoles holds the largest market share in 2016 and echinocandins is anticipated to grow at a cagr of 9.39% during the forecast period. Echinocandins are characterized by their capability to prevent synthesis of a key component of the fungal cell wall. Azole antifungals are characterized by the capability to prevent ergosterol synthesis in fungal membranes.the aspergillosis therapeutic indications market holds the largest market share in 2016 and will eventually continue to be the largest market domain in 2025. The candidiasis market is anticipated to grow at a faster rate. Aspergillosis refers to an infection that is caused by aspergillus i.e. A type of fungus. Such kind of fungus is often found in stored grain, dead leaves, and compost piles or in other decaying vegetation. It can also be present on marijuana leaves. Candidiasis refers to a fungal infection due to any type of yeast (candida). There are around twenty species of candida yeasts that can cause infections in human beings, amongst which the most common is candida albicans. Normally, candida yeasts exist on the skin and mucous membranes without causing infection, thus, overgrowth of these organisms can develop symptoms.

Global anti-fungal agent market in North America holds the largest market share in 2016 owing to its rising incidence of fungal infections and the development of novel antifungal biopharmaceuticals, etc. The major reason for the burgeoning growth in the region are the huge investments made in drug productions along with the government initiatives related to fungal infections and their treatment. The growth in the anti-fungal market in the United States is totally driven by its healthcare investment. However, Asia-Pacific would be the fastest growing region for global antifungal agents market. The major reason behind the success of this region is rising geriatric population along with rising awareness amongst people towards healthcare and personal care in developing countries like china, India, etc. Whereas, stringent regulatory approvals are hindering the growth of the market in Asia Pacific region. Europe’s market is anticipated to grow in the forecast year due to huge advantages of diversity.

Poor hygiene habits, development of drug resistance, healthcare policies and programs by government are the major drivers for the antifungal agents market. The market for an anti-fungal agent is continuously growing owing to the rising number of patients suffering from the hygiene related diseases majorly in the developing countries and also some of the developed countries. Conversely, factors inhibiting the market growth are alternate treatment options, regulatory atmosphere. The various market opportunities available in the market include healthcare and related industries are growing continuously, increasing awareness and availability of information. The growth in the healthcare industry from last few years supported by government initiatives have created significant growth opportunities for the antifungal agents market. Side effects and recurring fungal infections, resistance to drugs, rapidly changing technology are the major challenges within the growth of antifungal agents market.

Major players for the Antifungal Agents market are Abbott laboratories, Arbor pharmaceuticals Inc., 3 Baxter, Astellas pharma Inc., Bayer healthcare, Teva pharmaceuticals, Gilead, GlaxoSmithKline, Johnson & Johnson, Kramer laboratories, Merck & co., Novartis, Pfizer, Sanofi-Aventis, vertex pharmaceuticals. Major companies involved in this market are Astellas Pharma Inc., Johnson & Johnson, Teva pharma, Novartis, and Pfizer. Among all the companies involved, Astellas Pharma is the biggest in terms of production and market capitalization. The global market is growing because of the high demand of anti-fungal products. Companies are trying to capture more market share through various strategic initiatives.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
    • ESTIMATION METHODOLOGY
  3. EXECUTIVE SUMMARY
    • MARKET DEFINITION AND SCOPE
    • KEY FINDINGS
  4. MARKET DYNAMICS
    • DRIVERS
      • POOR HYGIENE HABITS
      • DEVELOPMENT OF DRUG RESISTANCE
      • HEALTHCARE POLICIES AND PROGRAMS BY GOVERNMENT
    • RESTRAINTS
      • ALTERNATE TREATMENT OPTIONS
      • REGULATORY ATMOSPHERE
    • OPPORTUNITIES
      • HEALTHCARE AND RELATED INDUSTRIES ARE GROWING CONTINUOUSLY
      • INCREASING AWARENESS AND AVAILABILITY OF INFORMATION
    • CHALLENGES
      • SIDE EFFECTS AND RECURRING FUNGAL INFECTIONS
      • RESISTANCE TO DRUGS
      • RAPIDLY CHANGING TECHNOLOGY
  1. MARKET SEGMENTATION
    • BY DRUG TYPES
      • ECHINOCANDINS MARKET
      • AZOLES MARKET
      • POLYENES MARKET
      • ALLYLAMINES MARKET
      • OTHERS MARKET
    • BY THERAPEUTIC INDICATIONS
      • ASPERGILLOSIS MARKET
      • DERMATOPHYTOSIS MARKET
      • CANDIDIASIS MARKET
      • OTHERS MARKET
    • BY APPLICATIONS
      • TOPICAL ANTIFUNGAL AGENTS MARKET
      • ORAL DRUGS MARKET
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
      • BARGAINING POWER OF BUYER
      • BARGAINING POWER OF SUPPLIER
      • INTENSITY OF COMPETITIVE RIVALRY
    • PESTEL ANALYSIS
    • KEY BUYING CRITERIA
    • VALUE CHAIN ANALYSIS
    • STRATEGIC RECOMMENDATION
    • STRATEGIC CONCLUSIONS
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)
      • UNITED STATES (U.S.) ANTIFUNGAL AGENTS MARKET
      • CANADA ANTIFUNGAL AGENTS MARKET
    • EUROPE ANTIFUNGAL AGENTS MARKET
      • UNITED KINGDOM (UK) ANTIFUNGAL AGENTS MARKET
      • FRANCE ANTIFUNGAL AGENTS MARKET
      • GERMANY ANTIFUNGAL AGENTS MARKET
      • SPAIN ANTIFUNGAL AGENTS MARKET
      • ITALY ANTIFUNGAL AGENTS MARKET
      • ROE ANTIFUNGAL AGENTS MARKET
    • ASIA PACIFIC ANTIFUNGAL AGENTS MARKET
      • INDIA ANTIFUNGAL AGENTS MARKET
      • CHINA ANTIFUNGAL AGENTS MARKET
      • JAPAN ANTIFUNGAL AGENTS MARKET
      • ROAPAC ANTIFUNGAL AGENTS MARKET
    • REST OF THE WORLD ANTIFUNGAL AGENTS MARKET
      • LATIN AMERICA ANTIFUNGAL AGENTS MARKET
      • MENA ANTIFUNGAL AGENTS MARKET
      • AFRICA ANTIFUNGAL AGENTS MARKET
  1. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
    • TOP WINNING STRATEGIES
  2. COMPANY PROFILES
    • ABBOTT LABORATORIES.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • ARBOR PHARMACEUTICALS, INC.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • BAXTER
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • ASTELLAS PHARMA INC.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • BAYER HEALTHCARE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVE
    • TEVA PHARMACEUTICALS
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • GILEAD
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVES
    • GLAXOSMITHKLINE
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC MOVES
    • JOHNSON & JOHNSON
      • OVERVIEW
      • PRODUCTS
      • SCOT ANALYSIS
      • STRATEGIC MOVES
    • KRAMER LABORATORIES
      • OVERVIEW
      • PRODUCTS
      • SCOT ANALYSIS
    • MERCK & CO.
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC MOVES
    • NOVARTIS
      • OVERVIEW
      • PRODUCTS
      • SCOT ANALYSIS
      • STRATEGIC MOVES
    • PFIZER
      • OVERVIEW
      • PRODUCTS
      • SCOT ANALYSIS
      • STRATEGIC MOVES
    • SANOFI-AVENTIS
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVE
    • VERTEX PHARMACEUTICALS
      • OVERVIEW
      • PRODUCT PORTFOLIO
      • SCOT ANALYSIS
      • STRATEGIC INITIATIVE

 

TABLE LIST           

TABLE # 1     GLOBAL ANTIFUNGAL AGENTS MARKET BY GEOGRAPHY 2017-2025 ($MILLION)

TABLE # 2     GLOBAL ANTIFUNGAL AGENTS MARKET BY DRUG TYPES MARKET 2017-2025 ($ MILLION)

TABLE # 3     INDICATION AND DOSES OF ECHINOCANDIN

TABLE # 4     GLOBAL ECHINOCANDINS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 5     DRUG USES OF TRIAZOLES

TABLE # 6     GLOBAL AZOLES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 7     GLOBAL POLYENES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 8     PRICE OF ALLYLAMINE ANTIFUNGALS

TABLE # 9     GLOBAL ALLYLAMINES MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 10   GLOBAL ANTIFUNGAL AGENTS MARKET BY THERAPEUTIC INDICATIONS MARKET 2017-2025 ($ MILLION)

TABLE # 11   GLOBAL ASPERGILLOSIS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 12   COMMON AFFECTED AREA – DERMATOPHYTES

TABLE # 13   GLOBAL DERMATOPHYTOSIS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 14   SYMPTOMS IN THE AFFECTED AREA CAUSED BY CANDIDIASIS

TABLE # 15   GLOBAL CANDIDIASIS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 16   GLOBAL OTHERS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 17   GLOBAL ANTIFUNGAL AGENTS MARKET BY APPLICATIONS MARKET 2017-2025 ($ MILLION)

TABLE # 18   PROS AND CONS OF TOPICAL MEDICATIONS

TABLE # 1     BRANDS OF ANTIFUNGAL POWDERS AND THEIR FUNCTIONALITY

TABLE # 2     BRANDS OF ANTIFUNGAL OINTMENTS AND THEIR FUNCTIONALITY

TABLE # 3     ANTIFUNGAL PASTES AND ITS EFFECT

TABLE # 4     COMMONLY USED ANTIFUNGAL DRUGS DOSAGE AND ITS EFFECTS

TABLE # 5     GLOBAL ANTI-FUNGAL AGENT MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

TABLE # 6     NORTH AMERICA ANTI-FUNGAL MARKET BY REGION 2017-2025 ($ MILLION)

TABLE # 7     EUROPE ANTI-FUNGAL AGENT MARKET 2017-2025 ($ MILLION)

TABLE # 8     FINAL CONSUMPTION OF MEDICAL GOODS AND SERVICES BY HOUSEHOLD

TABLE # 9     TOTAL BURDEN OF FUNGAL INFECTIONS IN SPAIN 2015

TABLE # 10   ASIA PACIFIC ANTIFUNGAL AGENTS MARKET BY REGION 2017-2025 ($ MILLION)

TABLE # 11   INDIA’S HEALTHCARE SECTOR INVESTMENT

TABLE # 12   COMPANIES IN CHINA PRODUCING ANTIFUNGAL DRUGS

TABLE # 13   TOTAL BURDEN OF FUNGAL INFECTIONS IN JAPAN

TABLE # 14   REST OF THE WORLD ANTIFUNGAL AGENTS MARKET BY REGION 2017-2025 ($ MILLION)

 

FIGURES LIST       

FIGURE # 1  GLOBAL ANTIFUNGAL AGENTS MARKET 2017-2025 ($MILLION)

FIGURE # 2  HEALTHCARE PROGRAMS INITIATED BY INDIAN GOVERNMENT

FIGURE # 1  ALTERNATIVE MEDICINE IN US (IN MILLION US DOLLARS)

FIGURE # 2  HEALTHCARE INDUSTRY IN THE WORLD IS RAPIDLY GROWING (%)

FIGURE # 3  GLOBAL ECHINOCANDINS MARKET 2017-2025 ($ MILLION)

FIGURE # 4  GLOBAL AZOLES MARKET 2017-2025 ($ MILLION)

FIGURE # 5  GLOBAL POLYENES MARKET 2017-2025 ($ MILLION)

FIGURE # 6  GLOBAL ALLYLAMINES MARKET 2017-2025 ($ MILLION)

FIGURE # 7  GLOBAL OTHERS MARKET 2017-2025 ($ MILLION)

FIGURE # 8  GLOBAL OTHERS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

FIGURE # 9  GLOBAL ASPERGILLOSIS MARKET 2017-2025 ($ MILLION)

FIGURE # 10            GLOBAL DERMATOPHYTOSIS MARKET 2017-2025 ($ MILLION)

FIGURE # 11            GLOBAL CANDIDIASIS MARKET 2017-2025 ($ MILLION)

FIGURE # 12            GLOBAL OTHERS MARKET 2017-2025 ($ MILLION)

FIGURE # 13            TOPICAL ANTIFUNGAL AGENTS TYPES

FIGURE # 14            GLOBAL TOPICAL ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)

FIGURE # 15            GLOBAL TOPICAL ANTIFUNGAL AGENTS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

FIGURE # 16            GLOBAL ORAL DRUGS MARKET 2017-2025 ($ MILLION)

FIGURE # 17            GLOBAL ORAL DRUGS MARKET BY GEOGRAPHY 2017-2025 ($ MILLION)

FIGURE # 18            PORTER’S FIVE FORCE MODEL IN ANTIFUNGAL AGENTS MARKET

FIGURE # 19            HEALTHCARE INVESTMENT IN THE U.S. 2012-2015 ($ BILLION)

FIGURE # 20            ANTI-FUNGAL AGENTS MARKET IN THE U.S.  2017-2025 ($ MILLION)

FIGURE # 21            CANADA ANTIFUNGAL AGENT MARKET 2017-2025 ($ MILLION)

FIGURE # 22            PHARMACEUTICAL SALES IN DIFFERENT COUNTRIES IN EUROPE 2014 ($ MILLION)

FIGURE # 23            HEALTHCARE EXPENDITURE IN UK 2010-2015 (£ BILLION)

FIGURE # 24            U.K. ANTIFUNGAL AGENTS MARKET 2017-2025 ($MILLION)

FIGURE # 25            INVESTMENT MADE BY DIFFERENT AGENTS IN FRANCE 2015 (%)

FIGURE # 26            FRANCE ANTI-FUNGAL AGENTS MARKET 2017-2025 ($ MILLION)

FIGURE # 27            GERMANY ANTI-FUNGAL AGENTS MARKET 2017-2025 ($ MILLION)

FIGURE # 28            SPAIN ANTI-FUNGAL MARKET 2017-2025 ($ MILLION)

FIGURE # 29            ITALY ANTI-FUNGAL MARKET 2017-2025 ($ MILLION)

FIGURE # 30            ROE ANTI-FUNGAL MARKET 2017-2025 ($ MILLION)

FIGURE # 31            PER CAPITA HEALTHCARE EXPENDITURE IN INDIA ($)

FIGURE # 32            INDIA ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)

FIGURE # 33            CHINA ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)

FIGURE # 34            JAPAN ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)

FIGURE # 35            ROAPAC ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)

FIGURE # 36            LATIN AMERICA ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)

FIGURE # 37            VARIOUS SECTORS INVESTMENTS IN THE MENA REGION

FIGURE # 38            MENA ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)

FIGURE # 39            AFRICA ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)

FIGURE # 40            GLOBAL ANTI-FUNGAL AGENT MARKET SHARE ANALYSIS

  1. MARKET SEGMENTATION
    • BY DRUG TYPES
      • ECHINOCANDINS MARKET
      • AZOLES MARKET
      • POLYENES MARKET
      • ALLYLAMINES MARKET
      • OTHERS MARKET
    • BY THERAPEUTIC INDICATIONS
      • ASPERGILLOSIS MARKET
      • DERMATOPHYTOSIS MARKET
      • CANDIDIASIS MARKET
      • OTHERS MARKET
    • BY APPLICATIONS
      • TOPICAL ANTIFUNGAL AGENTS MARKET
      • ORAL DRUGS MARKET
  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA ANTIFUNGAL AGENTS MARKET 2017-2025 ($ MILLION)
      • UNITED STATES (U.S.) ANTIFUNGAL AGENTS MARKET
      • CANADA ANTIFUNGAL AGENTS MARKET
    • EUROPE ANTIFUNGAL AGENTS MARKET
      • UNITED KINGDOM (UK) ANTIFUNGAL AGENTS MARKET
      • FRANCE ANTIFUNGAL AGENTS MARKET
      • GERMANY ANTIFUNGAL AGENTS MARKET
      • SPAIN ANTIFUNGAL AGENTS MARKET
      • ITALY ANTIFUNGAL AGENTS MARKET
      • ROE ANTIFUNGAL AGENTS MARKET
    • ASIA PACIFIC ANTIFUNGAL AGENTS MARKET
      • INDIA ANTIFUNGAL AGENTS MARKET
      • CHINA ANTIFUNGAL AGENTS MARKET
      • JAPAN ANTIFUNGAL AGENTS MARKET
      • ROAPAC ANTIFUNGAL AGENTS MARKET
    • REST OF THE WORLD ANTIFUNGAL AGENTS MARKET
      • LATIN AMERICA ANTIFUNGAL AGENTS MARKET
      • MENA ANTIFUNGAL AGENTS MARKET
      • AFRICA ANTIFUNGAL AGENTS MARKET

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.